LEGN Legend Biotech Corporation
LEGN Legend Biotech Corporation
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $18.45 · VWAP $23.33 · -17.4% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CFO, Director sold $308.6K, Sep 23–Oct 1
Coverage
2 watchlists
LEGN Price Structure
Loading timeframes…
Peers
Every watchlist LEGN belongs to, members best 30-day change first — LEGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Legend Biotech furnished its report for the period ended June 30, 2026 to the SEC on Form 6-K on August 11, 2026. No figures from this filing are recorded here.
full note →Against street estimates
How LEGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
LEGN research tape
70 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.